Newsbenzinga
Why Merck Just Slashed Its Profit Outlook By Nearly 50%
· Published
Article summary
Merck cuts FY2026 adjusted EPS outlook nearly in half to $2.66-$2.76, citing $2.43/share in charges from its Terns acquisition.
An excerpt from the original article.
Comments —
Loading comments…